Patents by Inventor Nils Peder WILLASSEN

Nils Peder WILLASSEN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230092081
    Abstract: The present invention relates to the use of a single-strand DNA binding protein (SSB) which exhibits at least 50% of its maximum ssDNA binding capability in the presence of 500 mM of sodium ions, to dehybridize a DNA molecule or to prevent hybridisation of a complementary ssDNA, wherein the SSB comprises the amino acid sequence of SEQ ID NO:1 or an amino acid sequence which is at least 75% identical to SEQ ID NO:1, or a functional fragment thereof, and wherein the DNA molecule or ssDNA is present in or exposed to a solution containing one or more of the following (i) at least 350 mM of sodium ions; (ii) at least 50 mM of potassium ions; (iii) at least 150 mM of magnesium ions; or (iv) at least 200 mM of calcium ions.
    Type: Application
    Filed: August 31, 2022
    Publication date: March 23, 2023
    Applicant: Universitetet I Tromsø - Norges Arktiske Universitet
    Inventors: Marcin PIERECHOD, Nils Peder WILLASSEN, Ulli ROTHWEILER
  • Patent number: 11447812
    Abstract: The present invention relates to the use of a single-strand DNA binding protein (SSB) which exhibits at least 50% of its maximum ssDNA binding capability in the presence of 500 mM of sodium ions, to dehybridize a DNA molecule or to prevent hybridisation of a complementary ssDNA, wherein the SSB comprises the amino acid sequence of SEQ ID NO:1 or an amino acid sequence which is at least 75% identical to SEQ ID NO:1, or a functional fragment thereof, and wherein the DNA molecule or ssDNA is present in or exposed to a solution containing one or more of the following (i) at least 350 mM of sodium ions; (ii) at least 50 mM of potassium ions; (iii) at least 150 mM of magnesium ions; or (iv) at least 200 mM of calcium ions.
    Type: Grant
    Filed: February 23, 2018
    Date of Patent: September 20, 2022
    Assignee: UNIVERSITETET I TROMSØ—NORGES ARKTISKE UNIVERSITET
    Inventors: Marcin Pierechod, Nils Peder Willassen, Ulli Rothweiler
  • Publication number: 20200332352
    Abstract: The invention provides an exonuclease or an enzymatically active fragment thereof, said exonuclease having the amino acid sequence of SEQ ID NO:1 or an amino acid sequence which is at least about 50% identical thereto, wherein said exonuclease or enzymatically active fragment thereof (i) is substantially irreversibly inactivated by heating at a temperature of about 55° C. for 10 minutes in a buffer consisting of 10 mM Tris-HCl, pH 8.5 at 25° C., 50 mM KCl and 5 mM MgCl2; (ii) is substantially specific for single stranded DNA; and (iii) has a 3?-5? exonuclease activity. The invention further provides a method of removing single stranded DNA from a sample, a method of nucleic acid amplification, a method of reverse transcription and a method of nucleic acid sequence analysis in which the exonuclease or enzymatically active fragment thereof is used.
    Type: Application
    Filed: August 13, 2019
    Publication date: October 22, 2020
    Applicants: ArcticZymes AS, Universitetet I Tromsø - Norges Arktiske Universitet
    Inventors: Terese SOLSTAD, Elisabeth Lill ANDREASSEN, Marit Sjo LORENTZEN, Olav LANES, Morten ELDE, Atle Noralf LARSEN, Yvonne PIOTROWSKI, Nils Peder WILLASSEN
  • Patent number: 10787702
    Abstract: The invention provides an exonuclease or an enzymatically active fragment thereof, said exonuclease having the amino acid sequence of SEQ ID NO:1 or an amino acid sequence which is at least about 50% identical thereto, wherein said exonuclease or enzymatically active fragment thereof (i) is substantially irreversibly inactivated by heating at a temperature of about 55° C. for 10 minutes in a buffer consisting of 10 mM Tris-HCl, pH 8.5 at 25° C., 50 mM KCl and 5 mM MgCl2; (ii) is substantially specific for single stranded DNA; and (iii) has a 3?-5? exonuclease activity. The invention further provides a method of removing single stranded DNA from a sample, a method of nucleic acid amplification, a method of reverse transcription and a method of nucleic acid sequence analysis in which the exonuclease or enzymatically active fragment thereof is used.
    Type: Grant
    Filed: August 13, 2019
    Date of Patent: September 29, 2020
    Assignees: ARCTICZYMES AS, UNIVERSITETET I TROMSø—NORGES ARKTISKE UNIVERSITET
    Inventors: Terese Solstad, Elisabeth Lill Andreassen, Marit Sjo Lorentzen, Olav Lanes, Morten Elde, Atle Noralf Larsen, Yvonne Piotrowski, Nils Peder Willassen
  • Publication number: 20200071753
    Abstract: The invention provides an exonuclease or an enzymatically active fragment thereof, said exonuclease having the amino acid sequence of SEQ ID NO:1 or an amino acid sequence which is at least about 50% identical thereto, wherein said exonuclease or enzymatically active fragment thereof (i) is substantially irreversibly inactivated by heating at a temperature of about 55° C. for 10 minutes in a buffer consisting of 10 mM Tris-HCl, pH 8.5 at 25° C., 50 mM KCl and 5 mM MgCl2; (ii) is substantially specific for single stranded DNA; and (iii) has a 3?-5? exonuclease activity. The invention further provides a method of removing single stranded DNA from a sample, a method of nucleic acid amplification, a method of reverse transcription and a method of nucleic acid sequence analysis in which the exonuclease or enzymatically active fragment thereof is used.
    Type: Application
    Filed: August 13, 2019
    Publication date: March 5, 2020
    Applicants: ArcticZymes AS, Universitetet I Tromsø - Norges Arktiske Universitet
    Inventors: Terese SOLSTAD, Elisabeth Lill ANDREASSEN, Marit Sjo LORENTZEN, Olav LANES, Morten ELDE, Atle Noralf LARSEN, Yvonne PIOTROWSKI, Nils Peder WILLASSEN
  • Publication number: 20190376122
    Abstract: The present invention relates to the use of a single-strand DNA binding protein (SSB) which exhibits at least 50% of its maximum ssDNA binding capability in the presence of 500 mM of sodium ions, to dehybridize a DNA molecule or to prevent hybridisation of a complementary ssDNA, wherein the SSB comprises the amino acid sequence of SEQ ID NO:1 or an amino acid sequence which is at least 75% identical to SEQ ID NO:1, or a functional fragment thereof, and wherein the DNA molecule or ssDNA is present in or exposed to a solution containing one or more of the following (i) at least 350 mM of sodium ions; (ii) at least 50 mM of potassium ions; (iii) at least 150 mM of magnesium ions; or (iv) at least 200 mM of calcium ions.
    Type: Application
    Filed: February 23, 2018
    Publication date: December 12, 2019
    Applicant: Universitetet I Tromsø - Norges Arktiske Universitet
    Inventors: Marcin PIERECHOD, Nils Peder WILLASSEN, Ulli ROTHWEILER
  • Patent number: 10415082
    Abstract: The invention provides an exonuclease or an enzymatically active fragment thereof, said exonuclease having the amino acid sequence of SEQ ID NO:1 or an amino acid sequence which is at least about 50% identical thereto, wherein said exonuclease or enzymatically active fragment thereof (i) is substantially irreversibly inactivated by heating at a temperature of about 55° C. for 10 minutes in a buffer consisting of 10 mM Tris-HCl, pH 8.5 at 25° C., 50 mM KCl and 5 mM MgCl2; (ii) is substantially specific for single stranded DNA; and (iii) has a 3?-5? exonuclease activity. The invention further provides a method of removing single stranded DNA from a sample, a method of nucleic acid amplification, a method of reverse transcription and a method of nucleic acid sequence analysis in which the exonuclease or enzymatically active fragment thereof is used.
    Type: Grant
    Filed: August 28, 2018
    Date of Patent: September 17, 2019
    Assignees: ARCTICZYMES AS, UNIVERSITETET I TROMSø—NORGES ARKTISKE UNIVERSITET
    Inventors: Terese Solstad, Elisabeth Lill Andreassen, Marit Sjo Lorentzen, Olav Lanes, Morten Elde, Atle Noralf Larsen, Yvonne Piotrowski, Nils Peder Willassen
  • Publication number: 20180363042
    Abstract: The invention provides an exonuclease or an enzymatically active fragment thereof, said exonuclease having the amino acid sequence of SEQ ID NO:1 or an amino acid sequence which is at least about 50% identical thereto, wherein said exonuclease or enzymatically active fragment thereof (i) is substantially irreversibly inactivated by heating at a temperature of about 55° C. for 10 minutes in a buffer consisting of 10 mM Tris-HCl, pH 8.5 at 25° C., 50 mM KCl and 5 mM MgCl2; (ii) is substantially specific for single stranded DNA; and (iii) has a 3?-5? exonuclease activity. The invention further provides a method of removing single stranded DNA from a sample, a method of nucleic acid amplification, a method of reverse transcription and a method of nucleic acid sequence analysis in which the exonuclease or enzymatically active fragment thereof is used.
    Type: Application
    Filed: August 28, 2018
    Publication date: December 20, 2018
    Applicants: ArcticZymes AS, Universitetet I Tromsø - Norges Arktiske Universitet
    Inventors: Terese Solstad, Elisabeth Lill Andreassen, Marit Sjo Lorentzen, Olav Lanes, Morten Elde, Atle Noralf Larsen, Yvonne Piotrowski, Nils Peder Willassen
  • Patent number: 10087483
    Abstract: The invention provides an exonuclease or an enzymatically active fragment thereof, said exonuclease having the amino acid sequence of SEQ ID No. 1 or an amino acid sequence which is at least about 50% identical thereto, wherein said exonuclease or enzymatically active fragment thereof (i) is substantially irreversibly inactivated by heating at a temperature of about 55° C. for 10 minutes in a buffer consisting of 10 mM Tris-HCI, pH 8.5 at 25° C., 50 mM KCI and 5 mM MgCI2; (ii) is substantially specific for single stranded DNA; and (iii) has a 3?-5? exonuclease activity. The invention further provides a method of removing single stranded DNA from a sample, a method of nucleic acid amplification, a method of reverse transcription and a method of nucleic acid sequence analysis in which the exonuclease or enzymatically active fragment thereof is used.
    Type: Grant
    Filed: August 19, 2015
    Date of Patent: October 2, 2018
    Assignees: ARCTICZYMES AS, UNIVERSITETET I TROMSØ—NORGES ARKTISKE UNIVERSITET
    Inventors: Terese Solstad, Elisabeth Lill Andreassen, Marit Sjo Lorentzen, Olav Lanes, Morten Elde, Atle Noralf Larsen, Yvonne Piotrowski, Nils Peder Willassen
  • Publication number: 20170233800
    Abstract: The invention provides an exonuclease or an enzymatically active fragment thereof, said exonuclease having the amino acid sequence of SEQ ID No. 1 or an amino acid sequence which is at least about 50% identical thereto, wherein said exonuclease or enzymatically active fragment thereof (i) is substantially irreversibly inactivated by heating at a temperature of about 55° C. for 10 minutes in a buffer consisting of 10 mM Tris-HCl, pH 8.5 at 25° C., 50 mM KCl and 5 mM MgCl2; (ii) is substantially specific for single stranded DNA; and (iii) has a 3?-5? exonuclease activity. The invention further provides a method of removing single stranded DNA from a sample, a method of nucleic acid amplification, a method of reverse transcription and a method of nucleic acid sequence analysis in which the exonuclease or enzymatically active fragment thereof is used.
    Type: Application
    Filed: August 19, 2015
    Publication date: August 17, 2017
    Applicants: ArcticZymes AS, Universitetet I Tromsø - Norges Arktiske Universitet
    Inventors: Terese SOLSTAD, Elisabeth Lill ANDREASSEN, Marit Sjo LORENTZEN, Olav LANES, Morten ELDE, Atle Noralf LARSEN, Yvonne PIOTROWSKI, Nils Peder WILLASSEN